Innova Biosciences
Antibody labeling and bioconjugation kits.
Launch date
Employees
Market cap
-
Enterprise valuation
€12m (Public information from Jun 2017)
Company register number 04415674
Over England (HQ)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Revenues | 2.9m | 5.7m | <1m | - | - | - |
% growth | - | 94 % | (86 %) | - | - | - |
EBITDA | <1m | 1.3m | (<1m) | - | - | - |
% EBITDA margin | 25 % | 23 % | (10 %) | - | - | - |
Profit | <1m | 1.2m | (<1m) | (<1m) | - | - |
% profit margin | 17 % | 21 % | (12 %) | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
€11.5m Valuation: €11.5m 3.9x EV/LTM Revenues 15.7x EV/LTM EBITDA | Acquisition | ||
Total Funding | - |
Recent News about Innova Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.